Evidence map›Paper›PMID 41638907›Full record

ArticleLife science alliance2026

Syk activation during FcγR-mediated phagocytosis involves Syk palmitoylation and desulfenylation.

Maxime Jansen, Jean-Marc Strub, Laurent Chaloin, Peter Coopman, Bruno Beaumelle

Abstract read
In one paragraph

Article in Life science alliance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maxime JansenInstitut de Recherche en Infectiologie de Montpellier, Université Montpellier, CNRS, Montpellier, France.ORCID 0000-0003-0774-2966
Jean-Marc StrubLaboratoire de Spectrométrie de Masse Bio-Organique, Université Strasbourg, CNRS, Strasbourg, France.ORCID 0000-0001-6224-3428
Laurent ChaloinInstitut de Recherche en Infectiologie de Montpellier, Université Montpellier, CNRS, Montpellier, France.ORCID 0000-0002-5757-5804
Peter CoopmanInstitut de Recherche en Cancérologie de Montpellier, Université Montpellier, ICM, INSERM, CNRS, Montpellier, France.ORCID 0000-0003-3720-523X
Bruno BeaumelleInstitut de Recherche en Infectiologie de Montpellier, Université Montpellier, CNRS, Montpellier, France bruno.beaumelle@irim.cnrs.fr.ORCID 0000-0002-4912-9134

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Syk tyrosine kinase acts downstream of several immune receptors such as the FcγR. Syk owns two SH2 domains that interact with biphosphorylated ITAMs of the FcγR upon phagocytosis. This results in the activation of Syk by autophosphorylation, triggering phosphorylation of several downstream targets, F-actin polymerization, and phagocytosis of the IgG-opsonized target. We found that Syk is S-acylated upon phagocytosis by macrophages. Palmitoylation is performed on a single Syk-Cys by the DHHC5 enzyme that specifically associates with Syk upon phagocytosis. Syk palmitoylation is important for Syk localization to the phagocytic cup, phosphorylation, and phagocytosis. We observed that another Syk-Cys residue, within a redox motif, is modified by sulfenylation. Nevertheless, Syk desulfenylation seems to occur during phagocytosis, when H

Indexed as

PhagocytosisReceptors, IgGSyk KinaseAnimalsHumansLipoylationMacrophagesMicePhosphorylationReceptors, IgGSyk KinaseSyk protein, mouse

Identifiers

PMID41638907
PMCPMC12872395

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.